HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA<sup>+</sup> liver metastases.

Katz, Steven C; Hardaway, John; Prince, Ethan; Guha, Prajna; Cunetta, Marissa; Moody, Ashley; Wang, Li Juan; Armenio, Vincent; Espat, N Joseph; Junghans, Richard P.
Cancer Gene Ther; 2019 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-31155611